Sandoz, a Swiss generic drug manufacturer, has filed an antitrust lawsuit in the U.S. They are accusing Amgen of illegally maintaining its market dominance of Enbrel…
Browsing: #BioTech
Johnson & Johnson plans to increase U.S. investments by 25% to over $55 billion in the next four years. The Trump administration’s threat of drug import…